Hatefi A - Search Results

1

MicroRNAs and lncRNAs-A New Layer of Myeloid-Derived Suppressor Cells Regulation.

Safarzadeh E, Asadzadeh Z, Safaei S, Hatefi A, Derakhshani A, Giovannelli F, Brunetti O, Silvestris N, Baradaran B. Safarzadeh E, et al. Among authors: hatefi a. Front Immunol. 2020 Oct 2;11:572323. doi: 10.3389/fimmu.2020.572323. eCollection 2020. Front Immunol. 2020. PMID: 33133086 Free PMC article. Review.

2

Development of a Recombinant Multifunctional Biomacromolecule for Targeted Gene Transfer to Prostate Cancer Cells.

Hatefi A, Karjoo Z, Nomani A. Hatefi A, et al. Biomacromolecules. 2017 Sep 11;18(9):2799-2807. doi: 10.1021/acs.biomac.7b00739. Epub 2017 Aug 24. Biomacromolecules. 2017. PMID: 28806522 Free PMC article.

3

Practical Issues with the Use of Stem Cells for Cancer Gene Therapy.

Nouri FS, Banerjee D, Hatefi A. Nouri FS, et al. Among authors: hatefi a. Stem Cell Rev Rep. 2015 Oct;11(5):688-98. doi: 10.1007/s12015-015-9605-9. Stem Cell Rev Rep. 2015. PMID: 26123358 Free PMC article. Review.

4

Reducing the Visibility of the Vector/DNA Nanocomplexes to the Immune System by Elastin-Like Peptides.

Nouri FS, Wang X, Chen X, Hatefi A. Nouri FS, et al. Among authors: hatefi a. Pharm Res. 2015 Sep;32(9):3018-28. doi: 10.1007/s11095-015-1683-5. Epub 2015 Mar 31. Pharm Res. 2015. PMID: 25823650

5

A novel chemotherapeutic protocol for peritoneal metastasis and inhibition of relapse in drug resistant ovarian cancer.

Sarkar S, Malekshah OM, Nomani A, Patel N, Hatefi A. Sarkar S, et al. Among authors: hatefi a. Cancer Med. 2018 Aug;7(8):3630-3641. doi: 10.1002/cam4.1631. Epub 2018 Jun 21. Cancer Med. 2018. PMID: 29926538 Free PMC article.

6

Bioengineered adipose-derived stem cells for targeted enzyme-prodrug therapy of ovarian cancer intraperitoneal metastasis.

Malekshah OM, Sarkar S, Nomani A, Patel N, Javidian P, Goedken M, Polunas M, Louro P, Hatefi A. Malekshah OM, et al. Among authors: hatefi a. J Control Release. 2019 Oct;311-312:273-287. doi: 10.1016/j.jconrel.2019.09.006. Epub 2019 Sep 6. J Control Release. 2019. PMID: 31499084 Free PMC article.

7

Genetically engineered theranostic mesenchymal stem cells for the evaluation of the anticancer efficacy of enzyme/prodrug systems.

Nouri FS, Wang X, Hatefi A. Nouri FS, et al. Among authors: hatefi a. J Control Release. 2015 Feb 28;200:179-87. doi: 10.1016/j.jconrel.2015.01.003. Epub 2015 Jan 7. J Control Release. 2015. PMID: 25575867 Free PMC article.

8

Enzyme/Prodrug Systems for Cancer Gene Therapy.

Malekshah OM, Chen X, Nomani A, Sarkar S, Hatefi A. Malekshah OM, et al. Among authors: hatefi a. Curr Pharmacol Rep. 2016 Dec;2(6):299-308. doi: 10.1007/s40495-016-0073-y. Epub 2016 Oct 19. Curr Pharmacol Rep. 2016. PMID: 28042530 Free PMC article.

9

Bioengineering a non-genotoxic vector for genetic modification of mesenchymal stem cells.

Chen X, Nomani A, Patel N, Nouri FS, Hatefi A. Chen X, et al. Among authors: hatefi a. Biomaterials. 2018 Jan;152:1-14. doi: 10.1016/j.biomaterials.2017.10.028. Epub 2017 Oct 20. Biomaterials. 2018. PMID: 29078136 Free PMC article. Review.

10

Gadolinium-labeled affibody-XTEN recombinant vector for detection of HER2+ lesions of ovarian cancer lung metastasis using quantitative MRI.

Nomani A, Li G, Yousefi S, Wu S, Malekshah OM, Nikkhoi SK, Pourfathi M, Rizi R, Hatefi A. Nomani A, et al. Among authors: hatefi a. J Control Release. 2021 Sep 10;337:132-143. doi: 10.1016/j.jconrel.2021.07.022. Epub 2021 Jul 18. J Control Release. 2021. PMID: 34284047 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

82 results

Search Page